| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
1 Geneva Cancer Registry, Institute for Social and Preventive Medicine, University of Geneva, Geneva, Switzerland
2 Senology and Surgical Gynecologic Oncology Unit, Department of Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland
3 Division of Oncology, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland
Correspondence: Address correspondence and reprint requests to: Christine Bouchardy, MD, PhD, Geneva Cancer Registry, 55 Boulevard de la Cluse, 1205 Geneva, Switzerland; E-mail: christine.bouchardy-magnin{at}imsp.unige.ch
Background: There is growing evidence that tumors of the inner quadrants (especially the lower-inner quadrant) metastasize more often to the internal mammary chain (IMC). As these metastases are not investigated, patients with lower-inner quadrant tumors have an increased risk of being under-staged and under-treated and may therefore have a higher risk of death from breast cancer.
Methods: We identified all 1522 women operated for stage I breast cancer between 1984 and 2002 recorded at the population-based Geneva Cancer Registry. We compared breast cancer mortality risk by tumor location with multivariate Cox regression analysis that accounted for all factors linked to tumor location and survival.
Results: Ten-year disease-specific survival was 93% (95%CI: 9194%). Patients with breast cancer of the lower-inner quadrant (n = 118; 7.8%) had an importantly increased risk of dying of breast cancer compared to women with breast cancer of the upper-outer quadrant (multiadjusted Hazard Ratio: 2.3, 95%CI: 1.14.5, P = 0.0206). The over-mortality associated with this quadrant was particularly evident for tumors >10 mm (multiadjusted HR: 3.6, 95%CI: 1.67.9, P = 0.0016). There was no increased breast cancer mortality risk for tumors located in other quadrants.
Conclusions: Tumor location in the lower-inner quadrant is an independent and important prognostic factor of stage I breast cancer. Further research is needed to evaluate if the over-mortality of patients with stage I cancer of the lower-inner quadrant is indeed a result of under-treatment due to undetected IMC metastases. If so, patients with stage I breast cancer of the lower-inner quadrant are good candidates for systematic IMC investigation.
Key Words: Breast cancer Early-stage Population-based Survival Tumor location
This article has been cited by other articles:
![]() |
U. Veronesi, P. Arnone, P. Veronesi, V. Galimberti, A. Luini, N. Rotmensz, E. Botteri, G. B. Ivaldi, M. C. Leonardi, G. Viale, et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series Ann. Onc., September 1, 2008; 19(9): 1553 - 1560. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |